Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019

JM Pogue, Y Zhou, H Kanakamedala, B Cai - BMC Infectious Diseases, 2022 - Springer
nosocomial pathogen that can lead to serious infectionsbaumannii infections have ranged
between 24 and 83% … comorbidities have a particularly high risk of mortality due to CR A. …

Mortality attributable to bloodstream infections caused by different carbapenem-resistant gram-negative bacilli: results from a nationwide study in Italy (ALARICO …

, … on Antimicrobial Resistant Infections … - Clinical Infectious …, 2023 - academic.oup.com
… Pseudomonas aeruginosa (CRPA), and CR Acinetobacter baumannii (CRAB) in the highest
priority … Bloodstream infections (BSIs) accounted for more than 70% of deaths attributable to …

Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based …

CH Su, LJ Chien, CT Fang, SC Chang - Plos one, 2023 - journals.plos.org
infections (HAIs), caused by the Acinetobacter baumannii, … baumannii can causes pneumonia,
bloodstream infections, … -year mortality by site of infection was highest for nosocomial

… and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

A Vivo, MA Fitzpatrick, KJ Suda, MM Jones… - BMC infectious …, 2022 - Springer
… have been identified as major causes of nosocomial infections due to their extensive … A
separate study had shown that 95% of deaths attributable to sepsis occurred within 28 …

… Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A …

X Zhen, C Stålsby Lundborg, X Sun, S Gu, H Dong - Antibiotics, 2020 - mdpi.com
… , due to the retrospective nature of our study, it is difficult to distinguish infection or colonization,
which may underestimate the clinical and economic outcome of carbapenem resistant

[HTML][HTML] Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia

CM Lee, CJ Kim, SE Kim, KH Park, JY Bae… - Journal of Global …, 2022 - Elsevier
… In this study, the 30-day mortality due to CRAB was quantified at 57.5%. This high mortality
of CRAB bacteraemia is consistent with the results of previous studies showing a 30-day …

Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients

S Karakonstantis, A Gikas, E Astrinaki… - Journal of Hospital …, 2020 - Elsevier
… other nosocomial infections and the risk of spreading PDRAB to other vulnerable patients. …
al. to estimate excess mortality due to carbapenem-resistant Klebsiella pneumoniae infection […

Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain

R Cantón, R Huarte, L Morata, JL Trillo-Mata… - … y Microbiología Clínica, 2021 - Elsevier
… , Pseudomonas aeruginosa and Acinetobacter baumannii) was analysed. Incidence and …
with CRGN nosocomial infections: Estimated mortality due to CRGN nosocomial infections in …

Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia

HJ Son, EB Cho, M Bae, SC Lee, H Sung… - … Forum Infectious …, 2020 - academic.oup.com
Acinetobacter baumannii, an aerobic, catalase-positive, oxidase-negative, gram-negative …
of human infections in the health care setting [1]. Two major nosocomial manifestations are …

Carbapenem resistance in Acinetobacter baumannii, and their importance in hospitalacquired infections: a scientific review

M Nguyen, SG Joshi - Journal of applied microbiology, 2021 - academic.oup.com
… This may prompt insight into the development of new agents or novel therapeutic strategies
for dealing with challenges associated with carbapenemresistant A. baumannii (CRAB) and …